Medications for Alcohol Use Disorders in a Primary Care Practice-Based Research Network Implementation Study

Autor:	Steven M. Ornstein, Lynne S. Nemeth, Andrea M. Wessell, Ruth G. Jenkins, Peter M. Miller
Rok vydání:	2014
Předmět:	Topiramate medicine.medical_specialty Referral business.industry Medicine (miscellaneous) Alcohol abuse Alcohol use disorder medicine.disease Practice-based research network Psychiatry and Mental health Acamprosate Disulfiram medicine Medical prescription Psychiatry business medicine.drug
Zdroj:	Alcoholism Treatment Quarterly. 32:58-66
ISSN:	1544-4538 0734-7324
DOI:	10.1080/07347324.2014.856224
Popis:	National Institute on Alcohol Abuse and Alcoholism recommendations encourage clinicians to consider the use of alcohol medications (ARx), acamprosate, disulfiram, naltrexone, or topiramate, for patients with alcohol use disorders (AUD). These recommendations have not yet been implemented in U.S. primary care practices. This mixed-methods substudy reports overall ARx use and facilitators to ARx use observed during a group-randomized trial in 19 practices. Nine percent of patients with a documented AUD diagnosis (n = 149 patients) received an ARx prescription. Facilitators to ARx use were exposure to evidence, limited referral options, receptive patients, successful outcomes, low cost of oral naltrexone, and familiarity with topiramate. Findings may affect the development of future primary care implementation programs.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::6919f20d37054e9bb73b8dfa316631a4 https://doi.org/10.1080/07347324.2014.856224 Zobrazit plný text záznamu